Project Details
Description
An open label multicenter extension study of Trastuzumab-mcc dm1 (TDM1)administered as a single agent or in combination with other anti-cancer therapies in patients previously treated with the equivalent TDM1 regimen
| Status | Finished |
|---|---|
| Effective start/end date | 8/30/11 → 1/20/16 |
Funding
- Genentech Inc.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.